# ICF - Institut Català de Finances

> ICF - Institut Català de Finances is a VC fund in Barcelona backing Health Care and Medical. See 15 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Barcelona, Spain
- Total investments: 15
- Last investment: Aug 2026
- Lead investor: 73%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/institut-catala-de-finances
- Website: https://www.icf.cat/ca/inici

ICF - Institut Català de Finances is a VC fund in Barcelona focused on Health Care and Medical. ICF - Institut Català de Finances provides financial services.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $2.4M–$2.9M |
| Debt Financing | $1.7M–$12M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 4 | 27% |
| Medical | 3 | 20% |
| Biotechnology | 3 | 20% |
| Veterinary | 2 | 13% |
| Manufacturing | 2 | 13% |

26 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Debt Financing | 10 | 67% |
| Seed | 2 | 13% |
| Funding Round | 1 | 7% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Spain | 12 | 80% |
| Germany | 1 | 7% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Delta Renovables | Delta Renovables specializes in the creation, promotion, operation, and maintenance of renewable energy projects. | $4.6M | Debt Financing | Aug 04, 2026 |  |
| Ercros | Ercros is a chemical manufacturing company that focuses on the basic products for the chemical and pharmaceutical industries. The company diversified in three areas of activity such as the Pharmacy Division, the Chlorine Derivatives Division, and the Intermediate Chemistry Division. It maintains a leading position in the main markets in which it ispresent and exports almost half of its sales to more than 128 countries, mainly in the EU.Ercros was founded in 1989 and is headquartered in Barcelona, Spain. | $22.8M | Post-IPO Debt | Jul 27, 2026 | http://www.ercros.es |
| Super's Diana | Super’s Diana develops, manufactures, and markets medicines and supplements for swine, cattle, and poultry livestock in over 30 countries. |  |  | May 07, 2026 | https://supersdiana.com |
| D-Sight | D-Sight is an early treatment for the leading cause of preventable blindness in the working-age population. | $2.4M | Seed | Feb 23, 2026 | https://www.dsight.es/ |
| Labiana Life Sciences | LABIANA GROUP has unique operational flexibility and a great capacity to offer high quality contract manufacturing services to all companies in the sector, regardless of batch size required. | $43.6M | Debt Financing | Feb 19, 2026 | http://www.labiana.com/ |
| Vytrus Biotech | Phyture Biotech was born as a spin-off company of the Faculty of Pharmacy at the Univerisity of Barcelona (Universitat de Barcelona), created by scientists from the research group Plant Biotechnology: Production of Phytomedicines (2009 SGR 1217). Phyture Biotech builds on the knowledge developed by this research group during more than 30 years,creating commercial products and solutions.Belonging to the Plant Biotechnology sector, Phyture Biotech is specialised in the production of high value active ingredients and recombinant proteins, for its use in the cosmetics and pharmaceutical sectors.Phyture has since renamed to Vytrus Biotech in 2016. | $2.3M | Debt Financing | Jan 14, 2026 | http://www.vytrus.com/ |
| Rubió | Rubió is a pharmaceutical company that offers medicines, diagnoses, and nutrition products. | $4.7M | Debt Financing | Jul 16, 2025 | https://x.com/labrubio |
| GEDIA | GEDIA develops and manufactures car body press parts and welding components for the automotive industry. | $9.5M | Debt Financing | May 06, 2025 | https://x.com/gedia1910 |
| Calsina Carré services | Calsina Carré Services offers parking, fueling, electric car charging and vehicle maintenance. | $11.8M | Debt Financing | Dec 11, 2024 | https://calsinacarreservices.com/es |
| Heecap | Heecap is a non-invasive, tailored electrostimulation technology that maintains respiratory muscle strength in these patients. | $2.9M | Seed | Dec 09, 2024 | https://www.heecap.com |

10 of 15 investments shown.

## Co-investors
- [Andbank](https://shizune.co/investors/profile/andbank) — VC Fund, 1 deal together
- [Aurica Capital](https://shizune.co/investors/profile/aurica-capital) — VC Fund, 1 deal together
- [Banco Santander’s Smart Fund](https://shizune.co/investors/profile/banco-santander-s-smart-fund) — VC Fund, 1 deal together
- [Banco Bbva Argentina SA](https://shizune.co/investors/profile/bbva-c51c) — VC Fund, 1 deal together
- [Bio Angels Club](https://shizune.co/investors/profile/bio-angels-club) — VC Fund, 1 deal together
- [CaixaBank](https://shizune.co/investors/profile/caixabank) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [ENISA](https://shizune.co/investors/profile/enisa-2) — VC Fund
- [Development Bank of Wales](https://shizune.co/investors/profile/development-bank-of-wales) — VC Fund
- [The FSE Group](https://shizune.co/investors/profile/finance-south-east) — VC Fund

### Similar country
- [ENISA](https://shizune.co/investors/profile/enisa-2) — VC Fund
- [Inveready](https://shizune.co/investors/profile/inveready-technology-investment-group) — VC Fund
- [Angels Capital](https://shizune.co/investors/profile/angels-capital) — VC Fund

## Featured in investor lists
- [Health Care Investors in Spain](https://shizune.co/investors/health-care-investors-spain)
- [Health Care VC Funds in Spain](https://shizune.co/investors/health-care-vc-funds-spain)
- [Climate Investors in Spain](https://shizune.co/investors/climate-investors-spain)
- [Climate VC Funds in Spain](https://shizune.co/investors/climate-vc-funds-spain)
- [Energy Investors in Spain](https://shizune.co/investors/energy-investors-spain)
- [Energy VC Funds in Spain](https://shizune.co/investors/energy-vc-funds-spain)

## FAQ

### What does ICF - Institut Català de Finances invest in?

ICF - Institut Català de Finances invests primarily in Health Care, Medical and Biotechnology startups, most often at Debt Financing and Seed stage. Most of the 15 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is ICF - Institut Català de Finances's check size?

ICF - Institut Català de Finances typically joins rounds of $2.4M–$2.9M at Seed and $1.7M–$12M at Debt Financing. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds ICF - Institut Català de Finances participates in.

### When did ICF - Institut Català de Finances last invest?

The most recent investment recorded for ICF - Institut Català de Finances closed in Aug 2026. Shizune tracks 15 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co